Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Gargling solution flies off Japan's shelves after governor touts anti-virus effect

Published 2020-08-05, 02:42 a/m
Updated 2020-08-05, 03:06 a/m
© Reuters. FILE PHOTO: Banners notifying sold-out of gargling medicine are displayed at empty shelves at a drugstore in Tokyo

TOKYO (Reuters) - Japanese drugstores were stripped bare of gargling solution by Wednesday, a day after the governor of the western prefecture of Osaka suggested it could help fight coronavirus, triggering panicked buying reminiscent of the early days of mask shortages.

Hundreds of thousands of people posted pictures of emptied shelves on Twitter, accompanied by handwritten "Out of Stock" notices, as they canvassed suggestions on how to acquire the coveted antiseptic.

"Anyone else having trouble buying gargling medicine? I'm coming to four misses now," wrote one user, @shotaro_1117, who posted images of four cleaned-out shelves.

On Tuesday, Osaka Governor Hirofumi Yoshimura said a study showed a smaller viral load in the saliva of 41 patients with mild symptoms after regular gargling with a medicine infused with povidone-iodine solution than in those who had not.

"Perhaps we can even overcome the coronavirus with gargling medicine," he told a mid-afternoon news conference, speaking of the study on those convalescing in regional hotels which was released by an Osaka hospital.

As the Japanese official spoke, shares of Meiji Holdings Co (T:2269), which sells a popular medicine previously marketed as Isojin, skyrocketed, gaining as much as 7.7% by late on Tuesday.

The shares were down 4% on Wednesday, but more than 1.2 million tweets had employed the hashtag #Isojin by afternoon.

As governments worldwide have struggled to rein in the virus, which has killed nearly 700,000 people and infected more than 18 million, some in authority have seized on any treatment seeming to offer a glimmer of hope.

For example, U.S. President Donald Trump has persistently promoted the unproven drug hydroxychloroquine as successful in treating the virus, and in April, he asked publicly if injecting disinfectant might help.

Japan's top government spokesman, Yoshihide Suga, said he was aware of the Osaka governor's comments, including the fact that researchers would try to determine if the ingredient could keep disease symptoms from worsening.

"The government will closely watch developments of the research," Suga told a news conference.

Some experts were sceptical, however.

"I think these kinds of claims might even lead to a high number of false negatives for PCR tests," pharmacist and medical writer Shuichi Aoshima wrote on Twitter, adding that tests after use of the germicide would register lower levels of the virus.

© Reuters. FILE PHOTO: Banners notifying sold-out of gargling medicine are displayed at empty shelves at a drugstore in Tokyo

"It's the same as dripping povidone-iodine onto a virus sample."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.